Will Regeneron Be Worth More Than Amazon by 2030?

When it comes to market value, Regeneron Pharmaceuticals (NASDAQ: REGN) may look like small potatoes compared to Amazon. The biotech company's market capitalization totals $61 billion. The e-commerce giant's market cap tops $1.7 trillion.

Still, Regeneron is among the biggest biotech companies in terms of market value. In a surprise move, coronavirus vaccine giants Moderna and BioNTech slipped ahead by that measure this year. But the Regeneron story is far from over. And that may signal gains in market value down the road.

But how much of a gain are we talking about? Could Regeneron actually be worth more than a massive company like Amazon by 2030? Let's find out.

Continue reading

Source Fool.com